Mölnlycke® Health Care and Transdiagen announce research collaboration to drive innovation in wound care

Contributed by: PR Newswire

Tags

MölnlyckeHealthcare

More Like This

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Europe faces a growing chronic wound crisis - time to act is now

Europe faces a growing chronic wound crisis - time to act is now

PR Newswire associated0

BioLab Holdings, Inc. Announces Strategic Investment in AI Diagnostic Technology

Dawn Health and Merck are collaborating to support Growth Disorders care

Mölnlycke® Health Care acquires P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturising

Mölnlycke and Ondine join forces against HAIs

PR Newswire associated0

TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions